David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Hexcel
HXL
$7B
| $21.5M | 0.03% |
311,230
-19,337
| -6% | -$1.3M |
|
677
Pitney Bowes
PBI
$2.27B
| $21.5M | 0.03% |
3,127,201
-825,235
| -21% | -$5.71M |
|
|
HIBB
678
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $21.5M | 0.03% |
941,789
+126,679
| +16% | +$2.23M |
|
679
D.R. Horton
DHI
$41.7B
| $21.5M | 0.03% |
518,936
-688,192
| -57% | -$26.9M |
|
680
CALL
eBay
EBAY
$47.7B
| $21.4M | 0.03% |
+577,200
| New | +$20M |
|
681
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $21.4M | 0.03% |
502,944
-86,700
| -15% | -$3.57M |
|
682
CALL
Workday
WDAY
$49.2B
| $21.3M | 0.03% |
110,700
+25,700
| +30% | +$4.67M |
|
683
Trinity Industries
TRN
$2.37B
| $21.3M | 0.03% |
982,362
+251,747
| +34% | +$5.75M |
|
684
PUT
United Rentals
URI
$67.4B
| $21.3M | 0.03% |
186,600
-69,500
| -27% | -$8.58M |
|
685
Iron Mountain
IRM
$36.1B
| $21.2M | 0.03% |
596,861
+136,931
| +30% | +$4.84M |
|
686
Kimberly-Clark
KMB
$37B
| $21.1M | 0.03% |
170,652
-188,546
| -52% | -$21.9M |
|
687
PUT
DuPont de Nemours
DD
$18.5B
| $21.1M | 0.03% |
156,294
-87,111
| -36% | -$12.1M |
|
688
CALL
Chegg
CHGG
$88.9M
| $21M | 0.03% |
+550,000
| New | +$20M |
|
|
AVTA
689
DELISTED
Avantax, Inc. Common Stock
AVTA
| $21M | 0.03% |
627,942
+56,880
| +10% | +$1.66M |
|
690
Avient
AVNT
$4.07B
| $20.9M | 0.03% |
713,941
+233,341
| +49% | +$7.32M |
|
|
PETQ
691
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $20.9M | 0.03% |
665,363
+23,679
| +4% | +$668K |
|
692
Dolby
DLB
$6.19B
| $20.9M | 0.03% |
331,803
+208,794
| +170% | +$13.3M |
|
|
RTEC
693
DELISTED
Rudolph Technologies Inc
RTEC
| $20.8M | 0.03% |
913,529
-86,377
| -9% | -$1.9M |
|
694
PUT
United Parcel Service
UPS
$87.4B
| $20.8M | 0.03% |
185,800
-493,200
| -73% | -$52.3M |
|
|
BMS
695
DELISTED
Bemis
BMS
| $20.7M | 0.03% |
373,897
+249,120
| +200% | +$12.7M |
|
696
HF Sinclair
DINO
$16.9B
| $20.7M | 0.03% |
419,276
+328,946
| +364% | +$17.5M |
|
697
Kirby Corp
KEX
$7.32B
| $20.6M | 0.03% |
274,650
-65,518
| -19% | -$4.77M |
|
698
Paylocity
PCTY
$8.09B
| $20.6M | 0.03% |
230,554
+40,351
| +21% | +$3.14M |
|
699
First Bancorp
FBP
$4.31B
| $20.4M | 0.03% |
1,778,258
+152,231
| +9% | +$1.61M |
|
|
CAJ
700
DELISTED
Canon, Inc.
CAJ
| $20.3M | 0.03% |
700,421
+72,946
| +12% | +$2.09M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.